Similarly, the expression of CD36 in liver tissues from MASLD patients showed a marked elevation, as demonstrated by IHC staining and Western blot analysis (Fig. 3E and F). This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.